NSE-INDEX
OUTLOOK – 28 November, 2016
For educational purpose only, please trade after consulting with your
advisor.
NIFTY 50: On last trading session we have seen a gain of 148.80 points (+1.9%) and closing at 8114.30. Now Nifty has entered
into the buying zone as it closed above its short term moving average. However
this trend is still subdued at Index is trading below its Long term Moving
Average.
Now what’s next: Nifty
saw a sharp rally on Friday and entered into buying zone but we are expecting
this rally may not continue. We have seen a continuous up move in US Dollar
index which we expect is negative for this market. A big Interest Rate cut by RBI can boost the
rally.
Support: 8064/7990/7950/7935/7897/7800/7777.
Resistance: 8161/8188/8205/8250/8296.
Now, nifty will enter into sell zone if
it close below 8097.50.
NIFTY BANK: On last trading session we have seen a moderate gain of 251.2 points
(+1.4%) however overall Index looks weak on the charts and it is still is sell
zone with negative sentiment. The key thing for consideration is that Nifty is
trading above its short term moving average and below its long term moving
average. However in the case of bank nifty, the case is opposite. Bank Nifty is
trading above its long term moving average however below its short term moving
average. So we are expecting that Nifty will come down to align with Bank
Nifty.
Over the weekend a great move from RBI to curb excess liquidity from
Market by announcing the CRR hike by
100% . This is negative for banking shares specially PSU Bank as they have to
deposit more money with RBI without getting any interest on that. We are
expecting Base rate cut from Bank at very high pace, because since they are not
getting any Return from RBI on his deposit, then why they will pay you 6%+
interest on FDR.
Support: 18140/18050/17980/17720 Resistance:
18540/18690/18780
On last trading session FIIs were net sellers of Rs. 372.88 Cr and DIIs
were net buyers of Rs. 997.84 Cr in Capital markets.
We believe the rally in NIFTY will be supported by NIFTY IT and NIFTY
Pharma.
No comments:
Post a Comment